Dave is dedicated to improving healthcare with innovative products and services. Prior to founding MedControl, Dave worked for Medica Corporation, a medical device firm in Boston, as both an Engineer and Quality Manager, and later served as the COO of Proximedics Technologies in Pittsburgh. Dave holds an MBA from Carnegie Mellon’s Tepper School of Business and BS in Mechanical Engineering from the University of Massachusetts – Dartmouth.
Dr. David brings over 25 years of experience practicing medicine in private and hospital settings. After experiencing the impact of medication non-adherence first-hand through the course of treatment, Dr. David endeavored to co-found MedControl to solve the problem. Dr. David holds a BS from the University of South Carolina and an MD from Ross University School of Medicine.
Steven is currently the President and CEO of Proximedics and previously served as co-founder and founding CEO of ClearCount Medical Solutions from 2004-2006 and CTO from 2006 to 2012. Steven provided business and technology leadership from the formation of the company through commercial launch and deployment of its breakthrough RFID products to hospitals across the U.S.
Steve also serves on the Board of Directors of REBIScan, and on the Advisory Board of Accel Diagnostics. Steve holds a BS in Applied Physics from Cornell University and an MBA from Carnegie Mellon University’s Tepper School of Business.
Dr. Dunn brings clinical expertise and over 25 years of experience as psychiatrist, medical research director, professor, and inventor. Researching neurophysiology in laboratories and treating patients in clinical settings gave Dr. Dunn both the insight to understand the need for a solution to medication non-adherence and the technical knowledge to bring to create it. Dr. Dunn holds a BA in Health Sciences from Kalamazoo College, and an MD from the University of Michigan in Ann Arbor.